NCT05584683View on ClinicalTrials.gov

A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

December 16, 2024

Study Completion Date

December 16, 2024

Conditions
PediatricBacterial Infections
Interventions
DRUG

Amoxicillin potassium clavulanate

LP-001 will be reconstituted and administered as a single dose

DRUG

Amoxicillin potassium clavulanate (Augmentin ES-600)

Augmentin ES-600 will be reconstituted and administered as a single dose

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors
All Listed Sponsors
lead

Kaizen Bioscience Co.

INDUSTRY

NCT05584683 - A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection | Biotech Hunter | Biotech Hunter